Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
Similar Companies760
Genomatica
Genomatica develops biobased process technologies to produce widely-used chemicals.
Sector
Subsector
Keywords
Location
total rounds
total raised
Zymochem
ZymoChem develops microbes that eliminate carbon loss during chemical production.
Sector
Subsector
Keywords
Location
total rounds
total raised
Visolis
Visolis is a bioengineering company that develops carbon-negative and sustainable chemicals.
Sector
Subsector
Location
total rounds
total raised
Alderys
Alderys develops biological engineering approaches to produce chemical compounds of economic interest from renewable plant resources.
Sector
Subsector
Keywords
Location
M&A Details1
Transaction name
Acquired by
Flexible Solutions International
announced date
Financials
Funding Rounds14
Number of Funding Rounds
Money Raised
Their latest funding was raised on 18.04.2022. Their latest round Venture - Series Unknown
CJ Cheiljedang
biotechnology, agriculture
count Of Investments
count Of Exists
US Department of Energy
The US Department of Energy addresses energy, environmental, and nuclear challenges through transformative science and technology.
Sector
Subsector
Location
count Of Investments
count Of Exists
Co-Investors
Investors19
Number of lead investors
Number of investors
National Science Foundation
The National Science Foundation (NSF) is an independent federal agency that funds scientific research and education in the United States.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Louis Beryl
3X Founder of Earnest, SolidEnergy, and now working on the next one. Formerly a16z and YC. Active angel investor and board member.
current job
organization founded
First Round Capital
First Round Capital is a seed-stage venture firm that helps technology entrepreneurs and companies build successful businesses.
Sector
Subsector
Location
count Of Investments
count Of Exists
Phin Barnes
Phin is a Sneakerhead and VC focused on building something new in the world of venture capital. He grew from unpaid intern to managing partner at First Round Capital, worked at AND 1 Basketball from “day 2″ and founded a fitness video game company. A basketball player in college, he’s since maintained his addiction to sneakers, love of hip-hop, and a decent trash-talk vocabulary. Phin lives in San Francisco with his wife and daughter.
current job
organization founded
Acquisitions1
Librede acquired by Lygos
acquirer
date
type
Librede
Librede Inc. creates sustainable technologies to improve life, including a biosynthetic production platform for yeast-based cannabinoids.
Sector
Subsector
Keywords
Location
total rounds
total raised
People
Founders3
Jeffrey Dietrich
Jeffrey Dietrich received his BS in Bioengineering from Rice University in 2005 and his PhD in Bioengineering from UC-Berkeley in 2011; Jeffrey was awarded a Siebel Scholarship in 2010 for his dissertation research in Dr. Jay Keasling’s laboratory at the Joint BioEnergy Institute. He is inventor of a series of next-generation high-throughput screening and selection technologies for improved microbial small-molecule biosynthesis. Jeffrey Co-Founded Lygos, Inc. in 2010 and is currently Chief Technology Officer. Lygos uses synthetic biology in combination with high-throughput screening approaches to engineer microbes for the production of chemicals. Lygos focuses on chemicals where biology has inherent cost advantages over petrochemical processes due to improved process yields, or elimination of hazardous waste streams.
current job
organization founded
Jeffrey Dietrich
Eric Steen
At Lygos, Dr. Steens' primary responsibilities include establishing a strategic vision, managing partnership and customer development, process commercialization, product development, and fundraising. Dr. Steen is an expert in optimizing sugar to product conversion efficiency, and prior to co-founding Lygos he led efforts to engineer yeast for the conversion of sugars into fuels and chemicals at the Department of Energy's Joint BioEnergy Institute; these technologies resulted in numerous peer-reviewed publications and patents, which are in various stages of commercialization. Dr. Steen earned a BS in Biomedical Engineering from Brown University in Providence, RI, and a Ph.D. in Bioengineering from UC Berkeley and UC San Francisco. While in graduate school, Dr. Steen completed a program in Management of Technology at UC Berkeley's Haas School of Business.
current job
organization founded
Eric Steen
Jay Keasling
Keasling is a Professor of Chemical engineering and Bioengineering at the University of California-Berkeley, Associate Laboratory Director at Lawrence Berkeley National Laboratory, Chief Executive Officer of the Joint BioEnergy Institute, and Director of the Synthetic Biology Engineering Research Center.He joined the UC-Berkeley faculty in 1992 and is considered one of the foremost authorities in synthetic biology, especially in the field of metabolic engineering. Dr. Keasling is also a co-founder of Codon Devices, Amyris, and LS9.
current job
organization founded
Jay Keasling
Employee Profiles10
Kevin Kaster
VP of Business Development & IP Strategy
Activity
Recent News4
The graph reveals the ratio (%) of positive news articles in a chosen time range